Clinical Trials Logo

Sodium Imbalance clinical trials

View clinical trials related to Sodium Imbalance.

Filter by:
  • None
  • Page 1

NCT ID: NCT06022133 Completed - Clinical trials for Obstructive Sleep Apnea of Adult

Sodium, Nocturnal Blood Pressure and Nocturnal Pauses in Breathing

ROSA
Start date: January 3, 2018
Phase: N/A
Study type: Interventional

A reduction of dietary sodium intake reduces blood pressure and risk of cardiovascular disease.

NCT ID: NCT05589428 Completed - Clinical trials for Heart Failure, Systolic

Low-salt Bread in Heart Failure, Pilot Study

Start date: February 20, 2018
Phase: N/A
Study type: Interventional

SUMMARY Rationale Patients with heart failure may suffer from a poor quality of life (QoL) due to frequent hospital admittance, medication intake, and symptoms as a result of progression of their disease. The general salt intake in the Dutch population is too high, leading indirectly to hypertension resulting in worsening of cardiovascular disease such as heart failure. Patients with heart failure are highly salt sensitive. A quarter of the daily salt intake originates from bread. Salt restriction is difficult to maintain. The aim of this study is to lower the daily salt intake by providing a palatable low salt bread to patients with heart failure. This may lead to a stable disease and therefore an improvement in quality of life. Objective The aim of this study is to investigate whether substitution of normal bread by a new palatable form of low salt bread is effective in reducing salt intake in patients with chronic heart failure. The investigators will evaluate the effectiveness, the compliance and the outcome of the presumed salt reduction. Study design This is a single center, randomized, double blinded, cross-over trial with a follow-up period of twelve weeks performed in VieCuri, Medical Centre in Venlo. Study population In this study, 20 patients visiting the outpatient clinic with heart failure NYHA class 3-4 will be included. All patients are 18 years or older. Intervention Given the study design all 20 patients receive a low salt bread (0.05 gram sodium per slice) for one period and received bread with a normal amount of sodium (0.35 gram sodium per slice) in the other period. After six weeks follow up, the groups change the intervention. Main study parameters/endpoints The investigators expect a reduction of daily salt intake of 1.5 gram sodium by an average of 5 slices bread a day. Nature and extent of the burden and risks associated with participation, benefit and group relatedness Patients should visit the hospital three times. Prior the hospital visit they have to collect 24- hour urine. During all visits blood samples will be taken and a physical exam is performed. Also blood pressure will be measured. Most of these parameters are also collected for clinical purposes. Patients should at the same time report their daily intake in a personal food diary and fill in questionnaires about their opinion of the bread and quality of life.

NCT ID: NCT04368546 Completed - Hypertension Clinical Trials

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Start date: November 1, 2015
Phase:
Study type: Observational

Here, it is investigated how sunitinib, a tyrosine kinase-inhibitor targeting vascular endothelial growth factor receptors, might influence sodium homeostasis in the skin and if this is related to a well-described treatment side-effect of sunitinib, hypertension.